We are happy to welcome you all to the first CCBIO Junior Scientist Symposium this semester, October 6th, 2022. This seminar series is a perfect place to meet and interact with other young scientists and we are very happy to announce that for the first time in years – it will be physical attendance only. We are very excited that Vladan Milosevic, a researcher at CCBIO will present the Hyperion – Image Mass cytometry System as our keynote presenter this time. As the debate in Norway is currently intense on what true women’s health is, we are looking forward to the presentations of our local junior researchers on topics related to 3D culturing of both ovarian and vulva cancer. We will also get updates on a clinical study investigating biomarkers for risk of blood clots during pregnancy. Finally, we will learn about mimicking clonal architecture in AML.
Please register within October 3rd at 11.00 as FREE LUNCH is included.
When: Thursday October 6th, 2022 at 09:00 – 13:00
Where: B307, Sentralblokka, Haukeland University Hospital
Registration: Link (Also even if you have registered for CCBIO901 in Studentweb.)
General information: More information about the Junior Scientist Symposia can be found here.
ECTS: Part of CCBIO901, with 3 credits (participation in the program through 2 terms.) All are however welcome for non-ECTS drop-in on each individual symposium. Perhaps you spot an interesting topic? Just remember to register!
09.15-10.00: “Multiplex profiling of the tumor microenvironment in breast cancer – Unlocking the power of mass cytometry” Keynote lecture by Vladan Milosevic
10.00-10.20: Coffee break
10.20-10.45: “Tumour-fibroblast interactions in squamous cell carcinomas” by Harsh Dongre
10.45-11.10: “Mimicking clonal architecture in Acute Myeloid Leukemia (AML)” by Tara Dowling
12:00-12:25: “Graviclot; Changes in coagulation activation in pregnancy and the puerperium in women with mild risk factors for venous thromboembolism” by Margunn Bye Tøsdal
12.25-12:50: “Establishment of peritoneal dECM scaffolds for culture of ovarian cancer organoids” by Christiane Helgestad Gjerde
12:50-13:00: Concluding remarks